Variant report
Variant | esv2493689 |
---|---|
Chromosome Location | chr2:209451033-209452683 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:209436667..209438687-chr2:209450893..209452499,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12993852 | chr2:209451085-209451086 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs377036397 | chr2:209451123-209451124 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181179467 | chr2:209451153-209451154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558333746 | chr2:209451155-209451156 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs578003814 | chr2:209451187-209451188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184840511 | chr2:209451261-209451262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189301967 | chr2:209451270-209451271 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573722821 | chr2:209451285-209451286 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541703909 | chr2:209451301-209451302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563481009 | chr2:209451328-209451329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs561623494 | chr2:209451376-209451377 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575330333 | chr2:209451384-209451385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547235828 | chr2:209451439-209451440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs564346801 | chr2:209451444-209451445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532886054 | chr2:209451496-209451497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149338095 | chr2:209451532-209451533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549879175 | chr2:209451560-209451561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569655959 | chr2:209451563-209451564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139095398 | chr2:209451573-209451574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs180899597 | chr2:209451576-209451577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549019400 | chr2:209451629-209451630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542482727 | chr2:209451638-209451639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs12613146 | chr2:209451694-209451695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs112029927 | chr2:209451732-209451733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112499496 | chr2:209451733-209451734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561119371 | chr2:209452014-209452015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113326760 | chr2:209452025-209452026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs535333248 | chr2:209452027-209452028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113719397 | chr2:209452034-209452035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs578157278 | chr2:209452040-209452041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201580442 | chr2:209452043-209452044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs199566691 | chr2:209452044-209452045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs116035046 | chr2:209452082-209452083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557066517 | chr2:209452096-209452097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573125001 | chr2:209452122-209452123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565132668 | chr2:209452124-209452125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191204204 | chr2:209452266-209452267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368855842 | chr2:209452271-209452272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181553046 | chr2:209452355-209452356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542801936 | chr2:209452499-209452500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs16841436 | chr2:209452512-209452513 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs550588417 | chr2:209452514-209452515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185972185 | chr2:209452528-209452529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191635850 | chr2:209452547-209452548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183098961 | chr2:209452561-209452562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543659853 | chr2:209452576-209452577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs563343487 | chr2:209452638-209452639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs6723561 | chr2:209452669-209452670 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:209438800-209459400 | Weak transcription | K562 | blood |
2 | chr2:209448200-209451400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr2:209449400-209458800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |